ClinicalTrialsFinder
RecruitingNCT05287022

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Sponsor

Arkansas Children's Hospital Research Institute

Enrollment

150 participants

Start Date

Jun 14, 2021

Study Type

OBSERVATIONAL

Conditions

Primary Ciliary Dyskinesia

Summary

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.

Eligibility

Min Age: 2 YearsMax Age: 99 Years

Inclusion Criteria13

  • Individuals who are diagnosed with Primary Ciliary Dyskinesia OR
  • Individuals with abnormal PCD diagnostics (abnormal ciliary biopsy or PCD genetics) OR
  • Individuals with unexplained bronchiectasis OR
  • Individuals undergoing PCD diagnostic testing (ciliary biopsy, PCD genetic testing) or concern based on clinical symptoms (at least two of the following):
  • Neonatal respiratory distress
  • Organ laterality defects
  • Year-round cough starting in first year of life or bronchiectasis on chest CT
  • Year-round nasal congestion starting in first year of life or pansinusitis
  • Multiple ear infections in the first two years of life with sequelae (e.g. ear tubes, chronic effusion, abnormal audiological exam)
  • History of recurrent pneumonias (at least 2 in one year or more than 3 at any time)
  • Ability to provide consent for participation in study by the participants or guardian
  • Ability to perform the test
  • Age \>= 2 years of age

Exclusion Criteria6

  • Individuals who are unable to understand the requirements of the study.
  • Individuals (or guardians) who are unwilling to provide consent.
  • Individuals who are unable to complete the testing
  • Recent history of sinus surgery (within four weeks) or bloody nose (within one week) of testing (they can be included at a later date)
  • Patients who are currently being treated (within one week) with antibiotics for sinusitis or respiratory symptoms (they can be included at a later date)
  • Age \<2 years of age
Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Arkansas Children's Hospital

Little Rock, Arkansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05287022

Related Trials

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

NCT072746311 location

DCP (RaDiCo Cohort) (RaDiCo-DCP)

NCT0595147832 locations

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

NCT072888271 location

Living With Primary Ciliary Dyskinesia (Living With PCD)

NCT046024811 location

Swiss Primary Ciliary Dyskinesia Registry

NCT036062001 location